DXL (DXLG) Q4 2025 Earnings Call Transcript

NodeGuardian · 2026-03-20T17:05:50+00:00

DXL Group faced a Q4 2025 sales decline to $112.1 million, with full-year sales at $435 million. The company is merging with FullBeauty Brands and focusing on strategic initiatives to stabilize and grow, targeting positive sales by 2026.

NodeGuardian

2026-03-20 17:05:50

Abstract generation in progress

DXL Group (DXLG) reported a Q4 2025 sales decline to $112.1 million and full-year sales of $435.0 million, with comparable sales down 7.3% and 8.4% respectively, impacted by severe weather and promotional activity. The company is progressing with its merger with FullBeauty Brands, expected to close in 2026, and is focusing on strategic initiatives like the FitMap rollout, expanding private brands, and refining marketing to stabilize the business and return to profitable growth. Despite current market challenges, including “customer malaise” and the impact of GLP-1 drugs, DXL aims for breakeven comparable sales before summer and positive comps later in 2026, driven by improved early 2026 sales momentum.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.